Literature DB >> 21069411

Atheroembolic renal disease with rapid progression and fatal outcome.

Bernardo Faria1, Joana Vidinha, Cátia Pêgo, Jesus Garrido, Sérgio Lemos, Carla Lima, Giovanni Sorbo, Edgar Lorga Gomes, Teresa Carvalho, Paulo Loureiro, Tânia Sousa.   

Abstract

Atheroembolic renal disease is caused by foreign-body reaction to cholesterol crystals flushed from the atherosclerotic plaques into the small-vessel system of the kidneys. It is an underdiagnosed entity, mostly related to vascular procedures and/or anticoagulation, and prognosis is considered to be poor. Besides the benefit of aggressive medical prevention of further embolic events, use of steroid therapy has been associated with greater survival. Here we report a case of a patient with a multisystemic presentation of the disease days after performance of percutaneous coronary intervention and anticoagulation initiation due to an episode of myocardial infarction. Renal, cutaneous, ophthalmic, neurological, and possibly muscular and mesenteric involvement was diagnosed. Although medical treatment with corticosteroids and avoidance of further anticoagulation was applied, the patient rapidly progressed to end-stage renal disease requiring hemodialysis and died 6 months after diagnosis. This is a case of catastrophic progression of the disease resistant to therapeutic measures. Focus on diagnosis and more efficient preventive and therapeutic protocols are therefore needed.

Entities:  

Mesh:

Year:  2010        PMID: 21069411     DOI: 10.1007/s10157-010-0363-3

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  29 in total

Review 1.  The evaluation of corticosteroid therapy in conjunction with plasma exchange in the treatment of renal cholesterol embolic disease. A report of 5 cases.

Authors:  M Hasegawa; S Kawashima; M Shikano; H Hasegawa; M Tomita; K Murakami; H Kushimoto; H Katsumata; T Toba; A Oohashi; S Hiramitsu; K Matsunaga
Journal:  Am J Nephrol       Date:  2000 Jul-Aug       Impact factor: 3.754

2.  Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: clinicopathological correlations.

Authors:  A Greenberg; S I Bastacky; A Iqbal; D Borochovitz; J P Johnson
Journal:  Am J Kidney Dis       Date:  1997-03       Impact factor: 8.860

3.  Vasculitis due to cholesterol embolism.

Authors:  Y Sijpkens; R Westendorp; F van Kemenade; S van Duinen; F Breedveld
Journal:  Am J Med       Date:  1997-03       Impact factor: 4.965

4.  Treatment of atheroembolization with corticosteroids.

Authors:  S J Mann; T A Sos
Journal:  Am J Hypertens       Date:  2001-08       Impact factor: 2.689

Review 5.  Cholesterol crystal embolism: diagnosis and treatment.

Authors:  A Meyrier
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

6.  The diagnostic dilemma of hypertensive nephrosclerosis: the nephrologist's view.

Authors:  P Zucchelli; A Zuccalà
Journal:  Am J Kidney Dis       Date:  1993-05       Impact factor: 8.860

7.  Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.

Authors:  Sylvie Lavaud; Eric Canivet; Anne Wuillai; Herve Maheut; Christine Randoux; Jeanne-Marie Bonnet; Jean-Louis Renaux; Jacques Chanard
Journal:  Nephrol Dial Transplant       Date:  2003-10       Impact factor: 5.992

Review 8.  Renal cholesterol embolic disease. Case report and review of the literature.

Authors:  W C Lye; J S Cheah; R Sinniah
Journal:  Am J Nephrol       Date:  1993       Impact factor: 3.754

Review 9.  Atheroembolic renal failure requiring dialysis: potential for renal recovery? A review of 43 cases.

Authors:  Josée Thériault; Mohsen Agharazzi; Marc Dumont; Vincent Pichette; Denis Ouimet; Martine Leblanc
Journal:  Nephron Clin Pract       Date:  2003

10.  The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors.

Authors:  Francesco Scolari; Pietro Ravani; Rossella Gaggi; Marisa Santostefano; Cristiana Rollino; Nevio Stabellini; Loredana Colla; Battista Fabio Viola; Paolo Maiorca; Chiara Venturelli; Stefano Bonardelli; Pompilio Faggiano; Brendan J Barrett
Journal:  Circulation       Date:  2007-07-02       Impact factor: 29.690

View more
  3 in total

1.  Prevalence and Associations of Retinal Emboli With Ethnicity, Stroke, and Renal Disease in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Disease Study.

Authors:  Ning Cheung; Kelvin Teo; Wanting Zhao; Jie Jin Wang; Kumari Neelam; Nicholas Y Q Tan; Paul Mitchell; Ching-Yu Cheng; Tien Yin Wong
Journal:  JAMA Ophthalmol       Date:  2017-10-01       Impact factor: 7.389

2.  Contrast induced nephropathy has to be differentiated from kidney injury due to atheroembolic disease.

Authors:  Hamid Nasri; Muhammed Mubarak
Journal:  J Renal Inj Prev       Date:  2013-09-01

Review 3.  Cholesterol Crystal Embolism and Chronic Kidney Disease.

Authors:  Xuezhu Li; George Bayliss; Shougang Zhuang
Journal:  Int J Mol Sci       Date:  2017-05-24       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.